1nhaler

Website
Current Valuation
$13.8M
As of November 17, 2025
Total Funding Raised
$4.5M
Last Round
Later Stage VC

$1.9M

Last Funding
Nov 2025

Funding date

Capital Efficiency
3.05x

Valuation / Funding

Interested in buying or selling 1nhaler shares?

Get a free quote from our secondary market team. We facilitate transactions from $250K to $500M+.

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

1nhaler is currently valued at $13.8M as of November 17, 2025. The company has raised a total of $4.5M in funding.

Capital Efficiency

With a capital efficiency ratio of 3.05x, 1nhaler has achieved a valuation that is 3.05 times the total capital raised.

Explore More Data
Detailed analysis for 1nhaler

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

See full funding history

Sign up to view 1nhaler's complete funding timeline, round details, and valuation progression.

What is 1nhaler Worth in 2026?

1nhaler is a leading private company in the technology sector. Track 1nhaler's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How 1nhaler Valuation is Determined

Private company valuations like 1nhaler's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.